Trial Profile
Low doses of etanercept can be effective to maintain remission in ankylosing spondylitis patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 07 Dec 2015 New trial record